Canine 1-DAPPvL2
A proven, combined vaccine that protects dogs against several highly contagious viruses and 2 leptospira serovars.
CANINE 1-DAPPVL2 PROVIDES PROTECTION AGAINST COMMONLY SPREAD VIRUSES
Canine Distemper Virus, Canine Adenovirus 2, Canine Parainfluenza Virus, Canine Parvovirus (modified live viruses), and Leptospira Canicola-Icterohaemorrhagiae (inactivated bacterin).
- Protects against all known strains of canine parvovirus (CPV), including CPV-2c2,3
- Contains CPV-2b, one of the most prevalent field strains of parvovirus
- High antigenic mass (titer), low passage parvovirus vaccine
- Overrides maternal antibodies in young puppies1
- Defends against 2 strains of Leptospira: L. canicola and L. icterohaemorrhagiae
- Protects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
- Provides disease coverage for commonly spread canine viruses, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus, in 1 formula
Indications:
Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper, adenovirus types 1 and 2, parainfluenza, parvovirus, and leptospiral disease due to L. canicola or L. icterohaemorrhagiae.
Recommended for use in healthy dogs 6 weeks of age or older.
ADMINISTRATION AND DOSAGE
- Subcutaneous or intramuscular injection
- Two 1 mL doses given 2 to 4 weeks apart
- Repeat at 2 to 4 week intervals until the dog is 12 weeks of age
- Annual revaccination with 1 dose is recommended
- Available in a 25 x 1 mL dose presentation
ALSO AVAILABLE IN OTHER FORMULATIONS
DISEASE INFORMATION
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
Quick Guide to Lepto
eBook
A handy guide to protect dogs and prevent the spread of leptospirosis.
Nobivac® Social Media Kits
Digital Assets
Use these ready-to-share posts to educate pet parents and drive business to your clinic for preventative care.
AAHA Canine Vaccination Guidelines
In-depth information about canine vaccinations and veterinary best practices.
No items to show.
References:
1. Data on file, Merck Animal Health.
2. Larson LJ, Schultz RD. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant? Vet Ther. 2008;9(2):94–101.
3. Schultz RD, Thiel B, Mukhtar E, Sharp P, Larson LJ. Age and long-term protective immunity in dogs and cats. J Comp Pathol. 2010;142 Suppl 1:S102–S108.
